FDA Releases Guidance for Levothyroxine Sodium Tablets Studies

Summary

The FDA has made available a guidance document to help pharmaceutical companies conduct in vivo pharmacokinetic and bioavailability studies and in vitro dissolution testing for levothyroxine sodium tablets, a key step in the development of new drug applications.